Financial services company Primerica (NYSE: PRI) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 8.6% year on year to $872.7 million. Its non-GAAP profit of $5.96 per share was 8.7% above analysts’ consensus estimates.

Is now the time to buy Primerica? Find out by accessing our full research report, it’s free.

Company Overview

With a sales force of over 140,000 licensed representatives operating on an independent contractor model, Primerica (NYSE: PRI) provides term life insurance, investment products, and other financial services to middle-income households in the United States and Canada.

Revenue Growth

Insurers earn revenue three ways. The core insurance business itself, often called underwriting and represented in the income statement as premiums earned, is one way. Investment income from investing the “float” (premiums collected upfront not yet paid out as claims) in assets such as fixed-income assets and equities is the second way. Fees from various sources such as policy administration, annuities, or other value-added services is the third. Luckily, Primerica’s revenue grew at a decent 7.7% compounded annual growth rate over the last five years. Its growth was slightly above the average insurance company and shows its offerings resonate with customers.

Long-term growth is the most important, but within financials, a half-decade historical view may miss recent interest rate changes and market returns. Primerica’s annualized revenue growth of 9% over the last two years is above its five-year trend, suggesting its demand recently accelerated. Note: Quarters not shown were determined to be outliers, impacted by outsized investment gains/losses that are not indicative of the recurring fundamentals of the business.

This quarter, Primerica reported year-on-year revenue growth of 8.6%, and its $872.7 million of revenue exceeded Wall Street’s estimates by 1.9%.

Net premiums earned made up 56.5% of the company’s total revenue during the last five years, meaning Primerica’s growth drivers strike a balance between insurance and non-insurance activities.

Markets consistently prioritize net premiums earned growth over investment and fee income, recognizing its superior quality as a core indicator of the company’s underwriting success and market penetration.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Book Value Per Share (BVPS)

Insurance companies are balance sheet businesses, collecting premiums upfront and paying out claims over time. The float–premiums collected but not yet paid out–are invested, creating an asset base supported by a liability structure. Book value per share (BVPS) captures this dynamic by measuring these assets (investment portfolio, cash, reinsurance recoverables) less liabilities (claim reserves, debt, future policy benefits). BVPS is essentially the residual value for shareholders.

We therefore consider BVPS very important to track for insurers and a metric that sheds light on business quality because it reflects long-term capital growth and is harder to manipulate than more commonly-used metrics like EPS.

Primerica’s BVPS grew at a solid 10.1% annual clip over the last five years. The last two years show a similar trajectory as BVPS grew by 10.5% annually from $63.16 to $77.12 per share.

Over the next 12 months, Consensus estimates call for Primerica’s BVPS to grow by 9.2% to $77.37, mediocre growth rate.

Key Takeaways from Primerica’s Q1 Results

We enjoyed seeing Primerica beat analysts’ revenue expectations this quarter. We were also glad its EPS outperformed Wall Street’s estimates. On the other hand, its net premiums earned slightly missed and its book value per share was in line with Wall Street’s estimates. Overall, this print was mixed but still had some key positives. The stock traded up 1.1% to $279.83 immediately after reporting.

So do we think Primerica is an attractive buy at the current price? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).